Today's Top Stories

View all

Advertisement

People in the News

View all
Browse by Specialty

More Stories

View all

Dynamic Tether Takes on Degenerative Spondylolisthesis

What if you could decompress the stenotic patient with Grade I spondylolisthesis without automatically reaching for an interbody cage?

PremiumSep 8, 2026
Dynamic Tether Takes on Degenerative Spondylolisthesis

Spine Surgeons Name Their Biggest Knowledge Gaps Globally

What did 400 spine and trauma surgeons say was their #1 knowledge gap?

PremiumSep 8, 2026
Spine Surgeons Name Their Biggest Knowledge Gaps Globally

350+ Hips Later: 3P Hip System Is Ready for Its Big-League Debut

OrthoPediatrics launches its new 3P Pediatric Plating Platform – after testing in a whopping 350 surgeon cohort.

PremiumSep 8, 2026
350+ Hips Later: 3P Hip System Is Ready for Its Big-League Debut

Long Fusion: To Iliac or Not to Iliac?

Intriguing new spine fusion registry study looks at long constructs and checks long-term re-op rates. You might be surprised.

PremiumSep 8, 2026
Long Fusion: To Iliac or Not to Iliac?

Bioretec receives FDA 510(k) clearance for its ActivaScrew™ Cannulated COM bioabsorbable compression screw

Sep 5, 2026
Bioretec receives FDA 510(k) clearance for its ActivaScrew™ Cannulated COM bioabsorbable compression screw

ArthroTAK Receives FDA 510(k) Clearance for Expanded Indications, Extending Sutureless Fixation Platform Across the Body

ArthroTAK, LLC has received FDA 510(k) clearance for expanded indications, extending the ArthroTAK® platform beyond its original shoulder applications into new areas of the body, including the knee, with additional anatomical applications in development.

Sep 4, 2026
ArthroTAK Receives FDA 510(k) Clearance for Expanded Indications, Extending Sutureless Fixation Platform Across the Body

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union

Globus Medical announced that the Excelsius3D™ intelligent 3-in-1 imaging system is now CE marked for commercial sale in the EU and the UK.

Sep 4, 2026
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union

FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing

Newly issued patent covers topical administration of 3D spheroid fibroblasts and fibroblast-derived materials to treat and accelerate the healing of wounds.

Sep 4, 2026
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing

INFUSE Bone Graft for TLIF receives eligibility for Medicare New Technology Add-on Payment, Advancing Reimbursement Support for Hospitals and Spine Surgeons

Medtronic announced that the CMS has granted a New Technology Add-on Payment (NTAP) for INFUSE™ Bone Graft for TLIF, effective October 1, 2026.

Sep 4, 2026
INFUSE Bone Graft for TLIF receives eligibility for Medicare New Technology Add-on Payment, Advancing Reimbursement Support for Hospitals and Spine Surgeons

Kinomatic Launches Unified Platform Built to Power the Next Generation of AI-Driven Orthopedic Surgical Care

 Kinomatic announced the launch of Kinect, a unified platform that connects surgical planning, case management, and surgeon collaboration for knee and hip joint replacement.

Sep 4, 2026
Kinomatic Launches Unified Platform Built to Power the Next Generation of AI-Driven Orthopedic Surgical Care

Nanochon Performs First Case in the Chondrograft™ First in Human Clinical Study

Nanochon announced the successful treatment of the first patient in its First-in-Human (FIH) clinical study of its Chondrograft cartilage implant.

Sep 4, 2026
Nanochon Performs First Case in the Chondrograft™ First in Human Clinical Study

Could a Trigger Finger Point Toward Amyloidosis?

Does amyloidosis in one muscle indicate future Amyloidosis in other muscles?

PremiumSep 4, 2026
Could a Trigger Finger Point Toward Amyloidosis?

Advertisement

Advertisement